Morgan Stanley Reiterates Overweight Rating on Gilead Sciences (GILD) Ahead of Yescarta and Zuma Data
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison reiterated an Overweight rating and $83.00 price target on Gilead Sciences (NASDAQ: GILD) noting that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE